Christian Weyer, M.D. has been appointed senior vice president, R&D at Amylin Pharmaceuticals. Orville Kolterman, M.D., has been named senior vice president, chief medical officer. These changes are intended to strengthen Amylin’s focus on preparations for a new product launch and the advancement of its late-stage development programs, according to a company statement. During his 10-year tenure at Amylin, Dr. Weyer has made valuable contributions to the business through leadership r...